Transitional cell carcinoma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 10: Line 10:
==Pathophysiology==
==Pathophysiology==
[[Genes]] involved in the [[pathogenesis]] of transitional cell carcinoma of bladder include [[HRAS]], [[Retinoblastoma protein|Rb1]], [[PTEN]]/MMAC1, NAT2, and GSTM1. On gross pathology, flat [[lesions]] or papillary lesions are characteristic findings of '''non-invasive''' transitional cell carcinomas; a large infiltrative [[mass]] or a multifocal, flat to papillary lesion with delicate fronds are characteristic findings of '''invasive''' transitional cell carcinomas. On microscopic histopathological analysis, loss of [[cell]] polarity, [[nuclear]] crowding, and cytologic [[atypia]] are characteristic findings of flat lesion; fibrovascular stalks, umbrella cells, and [[eosinophilic]] [[cytoplasm]] are characteristic findings of [[papillary]] lesion; invasion beyond the [[basement membrane]] is the characteristic finding of invasive transitional cell carcinomas.
[[Genes]] involved in the [[pathogenesis]] of transitional cell carcinoma of bladder include [[HRAS]], [[Retinoblastoma protein|Rb1]], [[PTEN]]/MMAC1, NAT2, and GSTM1. On gross pathology, flat [[lesions]] or papillary lesions are characteristic findings of '''non-invasive''' transitional cell carcinomas; a large infiltrative [[mass]] or a multifocal, flat to papillary lesion with delicate fronds are characteristic findings of '''invasive''' transitional cell carcinomas. On microscopic histopathological analysis, loss of [[cell]] polarity, [[nuclear]] crowding, and cytologic [[atypia]] are characteristic findings of flat lesion; fibrovascular stalks, umbrella cells, and [[eosinophilic]] [[cytoplasm]] are characteristic findings of [[papillary]] lesion; invasion beyond the [[basement membrane]] is the characteristic finding of invasive transitional cell carcinomas.
==Causes==
There are no established causes for transitional cell carcinoma.





Revision as of 13:43, 24 February 2016

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma overview

CDC on Transitional cell carcinoma overview

Transitional cell carcinoma overview in the news

Blogs on Transitional cell carcinoma overview

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transitional cell carcinoma is a type of cancer that originates in the kidney, bladder or ureter. It is the most common type of bladder cancer. It arises from the transitional epithelium lining found in these organs.

Classification

Based on the growth pattern, transitional cell carcinoma may be classified into either papillary urothelial carcinoma or non-papillary urothelial carcinoma. Transitional cell carcinoma may be classified according to World Health Organization in a collaborative effort conjointly with the International Society of Urological Pathologists (ISUP) into two groups: infiltrating urothelial carcinomas and non-invasive urothelial carcinomas.[1] Based on the degree of cellular differentiation, transitional cell carcinoma may be classified into two grades: low grade and high grade.

Pathophysiology

Genes involved in the pathogenesis of transitional cell carcinoma of bladder include HRAS, Rb1, PTEN/MMAC1, NAT2, and GSTM1. On gross pathology, flat lesions or papillary lesions are characteristic findings of non-invasive transitional cell carcinomas; a large infiltrative mass or a multifocal, flat to papillary lesion with delicate fronds are characteristic findings of invasive transitional cell carcinomas. On microscopic histopathological analysis, loss of cell polarity, nuclear crowding, and cytologic atypia are characteristic findings of flat lesion; fibrovascular stalks, umbrella cells, and eosinophilic cytoplasm are characteristic findings of papillary lesion; invasion beyond the basement membrane is the characteristic finding of invasive transitional cell carcinomas.

Causes

There are no established causes for transitional cell carcinoma.


References

  1. Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F (2002). "Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems". J Clin Pathol. 55 (12): 900–5. PMC 1769816. PMID 12461053.

Template:WH Template:WS